Overview
What is Jaime Leandro Foundation For Therapeutic Cancer Vaccines?
The Jaime Leandro Foundation for Therapeutic Cancer Vaccines, based in Chapel Hill, North Carolina, is a nonprofit organization with a mission to enhance access to and gather data about therapeutic neoantigen cancer vaccines. Through their Compassionate Access Vaccine Program, they create personalized neoantigen peptide vaccines for cancer patients, collaborating with experts in design, manufacture, and regulatory requirements. The foundation designs, manufactures, and delivers these personalized vaccines to treating physicians, facilitated by the FDA's Compassionate Access Protocol.
Official website here: www.jaimeleandrofoundation.org
Is Jaime Leandro Foundation For Therapeutic Cancer Vaccines legitimate?
Jaime Leandro Foundation For Therapeutic Cancer Vaccines is a legitimate nonprofit organization registered as a 501(c)(3) entity. Jaime Leandro Foundation For Therapeutic Cancer Vaccines submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.jaimeleandrofoundation.org
What is the mission statement of Jaime Leandro Foundation For Therapeutic Cancer Vaccines?
The Jaime Leandro Foundation for Therapeutic Cancer Vaccines is committed to improving access to and gathering data about therapeutic neoantigen cancer vaccines. Their mission is primarily focused on facilitating the provision of personalized neoantigen peptide vaccines for cancer patients through their Compassionate Access Vaccine Program. This program involves designing, manufacturing, and delivering personalized vaccines to treating physicians, utilizing the FDA's Compassionate Access Protocol and collaborating with experts in the relevant design, manufacturing, and regulatory requirements.
Official website here: www.jaimeleandrofoundation.org
Who is the CEO of Jaime Leandro Foundation For Therapeutic Cancer Vaccines?
William Hoos is the President of Jaime Leandro Foundation For Therapeutic Cancer Vaccines.
Official website here: www.jaimeleandrofoundation.org
What is the revenue of Jaime Leandro Foundation For Therapeutic Cancer Vaccines?
Jaime Leandro Foundation For Therapeutic Cancer Vaccines's revenue in 2022 was $1,344,079.
Official website here: www.jaimeleandrofoundation.org
Who are the executives of Jaime Leandro Foundation For Therapeutic Cancer Vaccines and what are their salaries?
- William Hoos (President) [Trustee/Director]
- Jason Chang (Treasurer) [Trustee/Director]
- William Gillanders (Board Member) [Trustee/Director]
- Malachi Griffith (Board Member) [Trustee/Director]
- Andrew Jacobs (Secretary) [Trustee/Director]
- Andrew Popp (Board Member) [Trustee/Director]
- J Martin Tenenbaum (Board Member) [Trustee/Director]
Official website here: www.jaimeleandrofoundation.org
Where can I find the form 990 for Jaime Leandro Foundation For Therapeutic Cancer Vaccines?
The Jaime Leandro Foundation For Therapeutic Cancer Vaccines’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.jaimeleandrofoundation.org
Learn more at the official website: www.jaimeleandrofoundation.org
Mission Statement of Jaime Leandro Foundation For Therapeutic Cancer Vaccines
The Jaime Leandro Foundation for Therapeutic Cancer Vaccines is committed to enhancing access to and gathering data about therapeutic neoantigen cancer vaccines. Through their Compassionate Access Vaccine Program, they aim to supply personalized neoantigen peptide vaccines to individuals battling cancer. The foundation collaborates with experts in design, manufacturing, and regulatory requirements to design, manufacture, and deliver these personalized vaccines to treating physicians via the FDA's Compassionate Access Protocol. This mission strives to improve the treatment options and outcomes for cancer patients, leveraging the power of targeted therapies and innovative vaccine technologies.
Impact
This information is meant to be a general summary of Jaime Leandro Foundation For Therapeutic Cancer Vaccines. Please take the time to review official sources before making any decisions based upon the content provided here.
Saturday, July 20, 2024
The Jaime Leandro Foundation For Therapeutic Cancer Vaccines is making a significant impact through its compassionate access vaccine program. By providing personalized neoantigen peptide vaccines for cancer patients, the foundation is improving access to innovative cancer treatments. Collaborating with experts in vaccine design, manufacture, and regulatory requirements, the foundation delivers these personalized vaccines to treating physicians through the FDA compassionate access protocol. This initiative is not only providing hope to patients but also generating valuable data about therapeutic neoantigen cancer vaccines that can potentially benefit many others in the future.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
PATIENT REVENUE
Revenue
$1,244,288
Organization Details
Founding Year
2020
Phone
(678) 793-7360
Principal Officer
William Hoos
Main Address
128 GRAYLYN DRIVE, CHAPEL HILL, NC, 27516
NTEE Category
Code: G30 - Disease
If you are a representative of Jaime Leandro Foundation For Therapeutic Cancer Vaccines and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.